A Study to Assess the Pharmacokinetics of CC-90001 in Subjects With Mild, Moderate, and Severe Hepatic Impairment Compared With Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 6, 2018

Primary Completion Date

June 10, 2019

Study Completion Date

June 10, 2019

Conditions

Hepatic Impairment

Interventions

DRUG

CC-90001

Trial Locations (4)

Orlando Clinical Research Center OCRC, Orlando

University of Miami Miller School of Medicine, Miami

Volunteer Research Group and New Orleans Center for Clinical Research - Knoxville, Knoxville

The Texas Liver Institute, San Antonio